SCHEMBL1344927

SCHEMBL1344927

CCOC(=O)c1c(C)n(C2CC2)c2c(OC)c(F)c(F)c(N)c2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRK6 P43250 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.37
HSD17B10 Q99714 2/20 0.37
NPC1 O15118 1/20 0.37
MITF O75030 1/20 0.37
TP53 P04637 1/20 0.37
RECQL P46063 1/20 0.37
RAB9A P51151 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
GSK3B P49841 5/20 0.36
MAPT P10636 6/20 0.34
GAA P10253 5/20 0.34
ALDH1A1 P00352 5/20 0.34
HPGD P15428 4/20 0.34
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
TOP2A P11388 1/20 0.32
TOP2B Q02880 1/20 0.32
POLB P06746 1/20 0.32
ALOX15 P16050 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1344302 0.87 GSK3B (0.40) GSK3BMEN1KMT2ATOP2ATOP2B
SCHEMBL1342925 0.85 GRK6 (0.43) GRK6SMN1; SMN2HSD17B10TP53RAB9A
SCHEMBL1345075 0.84 ALDH1A1 (0.40) GRK6SMN1; SMN2HSD17B10NPC1MITF
SCHEMBL1344855 0.75 GSK3B (0.52) GSK3BTOP2ATOP2BPOLBSTAT3
SCHEMBL1342252 0.73 GSK3B (0.44) GSK3BTOP2ATOP2BPOLB
SCHEMBL1344953 0.72 STAT3 (0.49) HSD17B10RAB9AGSK3BGAAALDH1A1
SCHEMBL4996383 0.71 USP2 (0.35) GRK6SMN1; SMN2HSD17B10NPC1MITF
SCHEMBL1344858 0.71 ALDH1A1 (0.38) GRK6HSD17B10NPSR1MAPTALDH1A1
SCHEMBL28404470 0.70 ADRB2 (0.39) GRK6NPC1RAB9AMEN1KMT2A
SCHEMBL1344612 0.70 GSK3B (0.49) GSK3BTOP2ATOP2BPOLBSTAT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2013182-B1 AMINOQUINOLONES AS GSK-3 INHIBITORS KYORIN SEIYAKU KK (JP) 2013-09-04 EP disclosed
EP-2383271-B1 Aminoquinolones as GSK-3 Inhibitors KYORIN SEIYAKU KK (JP) 2013-07-10 EP disclosed
US-8063221-B2 Aminoquinolones as GSK-3 inhibitors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-11-22 US disclosed
US-8063221-B2 Aminoquinolones as GSK-3 inhibitors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2011-11-22 US disclosed
EP-2383271-A1 Aminoquinolones as GSK-3 Inhibitors Kyorin Pharmaceutical Co., Ltd. (JP) 2011-11-02 EP disclosed
EP-2013182-A2 AMINOQUINOLONES AS GSK-3 INHIBITORS Activx Biosciences, Inc. (US) 2009-01-14 EP disclosed
US-20070254866-A1 Aminoquinolones as GSK-3 inhibitors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
US-20070254866-A1 Aminoquinolones as GSK-3 inhibitors KYORIN PHARMACEUTICAL CO., LTD. (JP) 2007-11-01 US disclosed
WO-2007106537-A2 AMINOQUINOLONES AS GSK-3 INHIBITORS ACTIVX BIOSCIENCES, INC. (US) 2007-09-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070254866-A1 Aminoquinolones as GSK-3 inhibitors GSK3B, GSK3A, GSKIP GRK6 1390/4885SMN1; SMN2 2797/4885HSD17B10 1297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.